Start up business idea in the field of pharmacogenetics

Abstract

[EN] Reducing drastically the cost of R&D expenditure in pharmaceutical pipeline is still a current challenge. Pharmacogenetic service firms are gradually integrating into the supply chain with the discovery of biomarkers or new drug target used to elaborate more personalized drugs. The quest for this project, after analyzing the value proposition of companies under the personalized medicine sector, is to find a market niche in the market of personalized medicine full of challenges but also, opportunities. After analyzing the pharmacogenetic service market, although it is still a new market but quite competitive, the main competitors in different sectors, a key value still to explore is the partnership with different firms for a more amplified source of genetic sample. This gives the drug discovery segment of R&D to start up with a solid source of targets for personalized drugs.